Comparison of platelet‐derived and plasma factor VIII efficacy using a novel native whole blood thrombin generation assay

Christina K. Baumgartner(AbbVie (United States)), Robert R. Montgomery(Scripps Health), Hartmut Weiler(Versiti Blood Center of Wisconsin), Qizhen Shi(Children's Hospital of Wisconsin), G. Zhang(Versiti Blood Center of Wisconsin), Erin L. Kuether(Medical College of Wisconsin)
Journal of Thrombosis and Haemostasis
October 10, 2015
10.1111/jth.13169
Cited by 14

Related Papers

Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council
|Journal of Pain|2016|3.1k
Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis
|Nature Medicine|2007|378
Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies
|Journal of Clinical Investigation|2006|188
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity
|Nature|2023|170
Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon.
|Journal of Clinical Investigation|1988|164